NCT02541149View on ClinicalTrials.gov

Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
PROCEDURE

blood sample

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02541149 - Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter